<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19
Image Overlay - Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19

Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19

Vanguard Clinical Research Trials Begin on Oral Medication for COVID-19

Vanguard Clinical Research has begun conducting trials an oral medication to relieve symptoms for people with a mild to moderate infection. “The research has been approved for 100 patients. Those are people who either think they have COVID-19, for which they’ll be tested, or they may have a common cold,” said Dr. Alan Tannenbaum, medical director of the clinical research team at Vanguard Clinical Research. In addition to helping clinical trials at facilities, Yourway is helping to lead the charge toward a more patient-centric supply chain by offering direct-to-patient services.

Back to Index
Media

Upcoming Events

GCSG 2024 US Conference

April 21-24, 2024
Naples, Florida

Precision in Clinical Trials Summit (Boston)

May 6-7, 2024
Hilton Boston Park Plaza

Media

Articles

Regulatory barriers in cross-border European pharmaceutical transport

Open chat
Come chat with us!
Hello! How can I help you?